2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Aims The aim of this study is to evaluate temporal trends, treatment, and clinical outcomes of
patients who present with an acute myocardial infarction (AMI) and have a current or …

Aims The post-discharge outcomes of patients with cancer who undergo PCI are not well
understood. This study evaluates the rates of readmissions within 90 days for acute …

Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the
population have led to an increasing number of cancer patients presenting with acute CV …

Cancer patients and survivors have elevated cardiovascular risk when compared with
noncancer patients. Cardio-oncology has emerged as a new subspecialty to comanage and …

Aims Primary percutaneous coronary intervention (pPCI) is the gold standard, guideline-
recommended revascularization strategy in patients presenting with ST-elevation …

Aim Expected 1‐year survival is essential to risk stratification of patients with heart failure
(HF); however, little is known about the 1‐year prognosis of patients with HF and cancer …

Aims Emerging evidence has linked cholesterol metabolism with platelet responsiveness.
We sought to examine the dose–response relationship between low-density lipoprotein …